Hepatitis

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

Survodutide Improves Liver Disease Progression in More than 80% of Patients with MASH
Survodutide Improves Liver Disease Progression in More than 80% of Patients with MASH

February 27th 2024

After 48 weeks of treatment with survodutide, patients demonstrated histological improvement, a reduction in liver fat content, and did not experience worsening fibrosis.

Eliminating Hepatitis C Virus Infections in Individuals who Inject Drugs: A Novel Model of Community Pharmacy Care
Eliminating Hepatitis C Virus Infections in Individuals who Inject Drugs: A Novel Model of Community Pharmacy Care

February 14th 2024

Structural detail of Hepatitis B virus on blue-green background. 3D illustration | Image Credit: Destina - stock.adobe.com
FDA Grants Fast Track Designation to Bepirovirsen for Chronic Hepatitis B

February 12th 2024

Macro of oxycodone opioid tablets | Image Credit: steheap - stock.adobe.com
Telemedicine Shows Increase in Curing Hepatitis C Virus Related to Opioid Use Disorder

November 20th 2023

Human liver anatomy with hepatitis virus. 3d illustration | Image Credit: Rasi - stock.adobe.com
Alcohol Consumption Not Found to Impact Sustained Virologic Response for Patients with Hepatitis C

October 3rd 2023

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.